These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 17661735

  • 1. Nebivolol: third-generation beta-blockade.
    de Boer RA, Voors AA, van Veldhuisen DJ.
    Expert Opin Pharmacother; 2007 Jul; 8(10):1539-50. PubMed ID: 17661735
    [Abstract] [Full Text] [Related]

  • 2. Nebivolol: a review of its use in the management of hypertension and chronic heart failure.
    Moen MD, Wagstaff AJ.
    Drugs; 2006 Jul; 66(10):1389-409; discussion 1410. PubMed ID: 16903772
    [Abstract] [Full Text] [Related]

  • 3. Metabolic profile of nebivolol, a beta-adrenoceptor antagonist with unique characteristics.
    Agabiti Rosei E, Rizzoni D.
    Drugs; 2007 Jul; 67(8):1097-107. PubMed ID: 17521213
    [Abstract] [Full Text] [Related]

  • 4. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
    Brodde OE, Philipp T.
    Dtsch Med Wochenschr; 2006 Nov 10; 131(45):2545-50. PubMed ID: 17091442
    [Abstract] [Full Text] [Related]

  • 5. Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release.
    Kamp O, Metra M, Bugatti S, Bettari L, Dei Cas A, Petrini N, Dei Cas L.
    Drugs; 2010 Nov 10; 70(1):41-56. PubMed ID: 20030424
    [Abstract] [Full Text] [Related]

  • 6. Nebivolol: a third-generation beta-blocker for hypertension.
    Cheng JW.
    Clin Ther; 2009 Mar 10; 31(3):447-62. PubMed ID: 19393838
    [Abstract] [Full Text] [Related]

  • 7. Clinical and economic aspects of the use of nebivolol in the treatment of elderly patients with heart failure.
    Del Sindaco D, Tinti MD, Monzo L, Pulignano G.
    Clin Interv Aging; 2010 Dec 03; 5():381-93. PubMed ID: 21152240
    [Abstract] [Full Text] [Related]

  • 8. Nebivolol, a vasodilating selective beta(1)-blocker, is a beta(3)-adrenoceptor agonist in the nonfailing transplanted human heart.
    Rozec B, Erfanian M, Laurent K, Trochu JN, Gauthier C.
    J Am Coll Cardiol; 2009 Apr 28; 53(17):1532-8. PubMed ID: 19389564
    [Abstract] [Full Text] [Related]

  • 9. Nebivolol: a review.
    Cockcroft J.
    Expert Opin Pharmacother; 2004 Apr 28; 5(4):893-9. PubMed ID: 15102571
    [Abstract] [Full Text] [Related]

  • 10. A review of the safety and efficacy of nebivolol in the mildly hypertensive patient.
    Cockcroft J.
    Vasc Health Risk Manag; 2007 Apr 28; 3(6):909-17. PubMed ID: 18200810
    [Abstract] [Full Text] [Related]

  • 11. Nitric oxide mechanisms of nebivolol.
    Maffei A, Lembo G.
    Ther Adv Cardiovasc Dis; 2009 Aug 28; 3(4):317-27. PubMed ID: 19443516
    [Abstract] [Full Text] [Related]

  • 12. Nebivolol: impact on cardiac and endothelial function and clinical utility.
    Toblli JE, DiGennaro F, Giani JF, Dominici FP.
    Vasc Health Risk Manag; 2012 Aug 28; 8():151-60. PubMed ID: 22454559
    [Abstract] [Full Text] [Related]

  • 13. [Beta-1 blockade plus NO release. Additional organ protection for patients with hypertension].
    MMW Fortschr Med; 2003 Oct 02; 145(40):57. PubMed ID: 14603611
    [No Abstract] [Full Text] [Related]

  • 14. Beta-blockers in the management of hypertension: focus on nebivolol.
    Wojciechowski D, Papademetriou V.
    Expert Rev Cardiovasc Ther; 2008 Apr 02; 6(4):471-9. PubMed ID: 18402537
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol.
    Kuroedov A, Cosentino F, Lüscher TF.
    Cardiovasc Drug Rev; 2004 Apr 02; 22(3):155-68. PubMed ID: 15492765
    [Abstract] [Full Text] [Related]

  • 16. The role of the new beta-blockers in treating cardiovascular disease.
    Weber MA.
    Am J Hypertens; 2005 Dec 02; 18(12 Pt 2):169S-176S. PubMed ID: 16373195
    [Abstract] [Full Text] [Related]

  • 17. Nebivolol for the treatment of heart failure.
    Riva N, Lip GY.
    Expert Opin Investig Drugs; 2011 Dec 02; 20(12):1733-46. PubMed ID: 21980961
    [Abstract] [Full Text] [Related]

  • 18. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
    van Veldhuisen DJ, Cohen-Solal A, Böhm M, Anker SD, Babalis D, Roughton M, Coats AJ, Poole-Wilson PA, Flather MD, SENIORS Investigators.
    J Am Coll Cardiol; 2009 Jun 09; 53(23):2150-8. PubMed ID: 19497441
    [Abstract] [Full Text] [Related]

  • 19. Nebivolol: a new antihypertensive agent.
    Gray CL, Ndefo UA.
    Am J Health Syst Pharm; 2008 Jun 15; 65(12):1125-33. PubMed ID: 18541682
    [Abstract] [Full Text] [Related]

  • 20. Nebivolol: an endothelium-friendly selective β1-adrenoceptor blocker.
    Gao Y, Vanhoutte PM.
    J Cardiovasc Pharmacol; 2012 Jan 15; 59(1):16-21. PubMed ID: 21283024
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.